Literature DB >> 23111546

DSM-5 field trials in the United States and Canada, Part I: study design, sampling strategy, implementation, and analytic approaches.

Diana E Clarke1, William E Narrow, Darrel A Regier, S Janet Kuramoto, David J Kupfer, Emily A Kuhl, Lisa Greiner, Helena C Kraemer.   

Abstract

OBJECTIVE: This article discusses the design,sampling strategy, implementation,and data analytic processes of the DSM-5 Field Trials.
METHOD: The DSM-5 Field Trials were conducted by using a test-retest reliability design with a stratified sampling approach across six adult and four pediatric sites in the United States and one adult site in Canada. A stratified random sampling approach was used to enhance precision in the estimation of the reliability coefficients. A web-based research electronic data capture system was used for simultaneous data collection from patients and clinicians across sites and for centralized data management.Weighted descriptive analyses, intraclass kappa and intraclass correlation coefficients for stratified samples, and receiver operating curves were computed. The DSM-5 Field Trials capitalized on advances since DSM-III and DSM-IV in statistical measures of reliability (i.e., intraclass kappa for stratified samples) and other recently developed measures to determine confidence intervals around kappa estimates.
RESULTS: Diagnostic interviews using DSM-5 criteria were conducted by 279 clinicians of varied disciplines who received training comparable to what would be available to any clinician after publication of DSM-5.Overall, 2,246 patients with various diagnoses and levels of comorbidity were enrolled,of which over 86% were seen for two diagnostic interviews. A range of reliability coefficients were observed for the categorical diagnoses and dimensional measures.
CONCLUSIONS: Multisite field trials and training comparable to what would be available to any clinician after publication of DSM-5 provided “real-world” testing of DSM-5 proposed diagnoses.

Entities:  

Mesh:

Year:  2013        PMID: 23111546     DOI: 10.1176/appi.ajp.2012.12070998

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   18.112


  34 in total

Review 1.  DSM-5 ASD moves forward into the past.

Authors:  Luke Y Tsai; Mohammad Ghaziuddin
Journal:  J Autism Dev Disord       Date:  2014-02

2.  Barriers to implementing the DSM-5 cultural formulation interview: a qualitative study.

Authors:  Neil Krishan Aggarwal; Andel Veronica Nicasio; Ravi DeSilva; Marit Boiler; Roberto Lewis-Fernández
Journal:  Cult Med Psychiatry       Date:  2013-09

3.  The DSM-5: Classification and criteria changes.

Authors:  Darrel A Regier; Emily A Kuhl; David J Kupfer
Journal:  World Psychiatry       Date:  2013-06       Impact factor: 49.548

4.  Network models of DSM-5 posttraumatic stress disorder: Implications for ICD-11.

Authors:  Karen S Mitchell; Erika J Wolf; Michelle J Bovin; Lewina O Lee; Jonathan D Green; Raymond C Rosen; Terence M Keane; Brian P Marx
Journal:  J Abnorm Psychol       Date:  2017-02-13

5.  How well are DSM-5 diagnostic criteria for ASD represented in standardized diagnostic instruments?

Authors:  Kris Evers; Jarymke Maljaars; Sarah J Carrington; Alice S Carter; Francesca Happé; Jean Steyaert; Susan R Leekam; Ilse Noens
Journal:  Eur Child Adolesc Psychiatry       Date:  2020-02-19       Impact factor: 4.785

6.  The True North Strong and Free? Opportunities for Improving Canadian Mental Health Care and Education by Adopting the WHO's ICD-11 Classification.

Authors:  Cary S Kogan; Sabrina Paterniti
Journal:  Can J Psychiatry       Date:  2017-06-30       Impact factor: 4.356

7.  The ICD-11 developmental field study of reliability of diagnoses of high-burden mental disorders: results among adult patients in mental health settings of 13 countries.

Authors:  Geoffrey M Reed; Pratap Sharan; Tahilia J Rebello; Jared W Keeley; María Elena Medina-Mora; Oye Gureje; José Luis Ayuso-Mateos; Shigenobu Kanba; Brigitte Khoury; Cary S Kogan; Valery N Krasnov; Mario Maj; Jair de Jesus Mari; Dan J Stein; Min Zhao; Tsuyoshi Akiyama; Howard F Andrews; Elson Asevedo; Majda Cheour; Tecelli Domínguez-Martínez; Joseph El-Khoury; Andrea Fiorillo; Jean Grenier; Nitin Gupta; Lola Kola; Maya Kulygina; Itziar Leal-Leturia; Mario Luciano; Bulumko Lusu; J Nicolas; I Martínez-López; Chihiro Matsumoto; Lucky Umukoro Onofa; Sabrina Paterniti; Shivani Purnima; Rebeca Robles; Manoj K Sahu; Goodman Sibeko; Na Zhong; Michael B First; Wolfgang Gaebel; Anne M Lovell; Toshimasa Maruta; Michael C Roberts; Kathleen M Pike
Journal:  World Psychiatry       Date:  2018-06       Impact factor: 49.548

8.  Persistent Depression: Should Such a DSM-5 Diagnostic Category Persist?

Authors:  Gordon Parker; Gin S Malhi
Journal:  Can J Psychiatry       Date:  2018-11-19       Impact factor: 4.356

9.  DSM-5 cross-cutting symptom measures: a step towards the future of psychiatric care?

Authors:  Diana E Clarke; Emily A Kuhl
Journal:  World Psychiatry       Date:  2014-10       Impact factor: 49.548

10.  Feasibility and acceptability of the DSM-5 Field Trial procedures in the Johns Hopkins Community Psychiatry Programs.

Authors:  Diana E Clarke; Holly C Wilcox; Leslie Miller; Bernadette Cullen; Joan Gerring; Lisa H Greiner; Alison Newcomer; Mellisha V McKitty; Darrel A Regier; William E Narrow
Journal:  Int J Methods Psychiatr Res       Date:  2014-02-25       Impact factor: 4.035

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.